[HTML][HTML] The P132H mutation in the main protease of Omicron SARS-CoV-2 decreases thermal stability without compromising catalysis or small-molecule drug …
Dear Editor, The ongoing SARS-CoV-2 pandemic continues to be a significant threat to
global health. First reported in November 2021, the Omicron variant (B. 1.1. 529) is more …
global health. First reported in November 2021, the Omicron variant (B. 1.1. 529) is more …
The P132H mutation in the main protease of Omicron SARS-CoV-2 decreases thermal stability without compromising catalysis or small-molecule drug inhibition
MD Sacco, Y Hu, MV Gongora, F Meilleur, MT Kemp… - bioRxiv, 2022 - biorxiv.org
The ongoing SARS-CoV-2 pandemic continues to be a significant threat to global health.
First reported in November 2021, the Omicron variant (B. 1.1. 529) is more transmissible and …
First reported in November 2021, the Omicron variant (B. 1.1. 529) is more transmissible and …
The P132H mutation in the main protease of Omicron SARS-CoV-2 decreases thermal stability without compromising catalysis or small-molecule drug inhibition
MD Sacco, Y Hu, MV Gongora, F Meilleur, MT Kemp… - 2022 - pesquisa.bvsalud.org
The P132H mutation in the main protease of Omicron SARS-CoV-2 decreases thermal
stability without compromising catalysis or small-molecule drug inhibition | PREPRINT-BIORXIV …
stability without compromising catalysis or small-molecule drug inhibition | PREPRINT-BIORXIV …
[HTML][HTML] The P132H mutation in the main protease of Omicron SARS-CoV-2 decreases thermal stability without compromising catalysis or small-molecule drug …
MD Sacco, Y Hu, MV Gongora, F Meilleur, MT Kemp… - 2022 - europepmc.org
The ongoing SARS-CoV-2 pandemic continues to be a significant threat to global health.
First reported in November 2021, the Omicron variant (B. 1.1. 529) is more transmissible and …
First reported in November 2021, the Omicron variant (B. 1.1. 529) is more transmissible and …
[HTML][HTML] The P132H mutation in the main protease of Omicron SARS-CoV-2 decreases thermal stability without compromising catalysis or small-molecule drug …
MD Sacco, Y Hu, MV Gongora, F Meilleur… - Cell …, 2022 - ncbi.nlm.nih.gov
Dear Editor, The ongoing SARS-CoV-2 pandemic continues to be a significant threat to
global health. First reported in November 2021, the Omicron variant (B. 1.1. 529) is more …
global health. First reported in November 2021, the Omicron variant (B. 1.1. 529) is more …
The P132H mutation in the main protease of Omicron SARS-CoV-2 decreases thermal stability without compromising catalysis or small-molecule drug inhibition
MD Sacco, Y Hu, MV Gongora, F Meilleur, MT Kemp… - Cell Research, 2022 - osti.gov
The ongoing SARS-CoV-2 pandemic continues to be a significant threat to global health.
First reported in November 2021, the Omicron variant (B. 1.1. 529) is more transmissible and …
First reported in November 2021, the Omicron variant (B. 1.1. 529) is more transmissible and …
[PDF][PDF] The P132H mutation in the main protease of Omicron SARS-CoV-2 decreases thermal stability without compromising catalysis or small-molecule drug inhibition
MD Sacco, Y Hu, MV Gongora, F Meilleur, MT Kemp… - scholar.archive.org
The ongoing SARS-CoV-2 pandemic continues to be a significant threat to global health.
First reported in November 2021, the Omicron variant (B. 1.1. 529) is more transmissible and …
First reported in November 2021, the Omicron variant (B. 1.1. 529) is more transmissible and …
[引用][C] The P132H mutation in the main protease of Omicron SARS-CoV-2 decreases thermal stability without compromising catalysis or small-molecule drug inhibition
MD Sacco, Y Hu, MV Gongora, F Meilleur… - Cell …, 2022 - pubmed.ncbi.nlm.nih.gov
The P132H mutation in the main protease of Omicron SARS-CoV-2 decreases thermal stability
without compromising catalysis or small-molecule drug inhibition The P132H mutation in the …
without compromising catalysis or small-molecule drug inhibition The P132H mutation in the …
[引用][C] The P132H mutation in the main protease of Omicron SARS-CoV-2 decreases thermal stability without compromising catalysis or small-molecule drug inhibition
MD Sacco, Y Hu, MV Gongora, F Meilleur… - Cell …, 2022 - researchwithrutgers.com
The P132H mutation in the main protease of Omicron SARS-CoV-2 decreases thermal stability
without compromising catalysis or small-molecule drug inhibition — Rutgers, The State …
without compromising catalysis or small-molecule drug inhibition — Rutgers, The State …
The P132H mutation in the main protease of Omicron SARS-CoV-2 decreases thermal stability without compromising catalysis or small-molecule drug inhibition
MD Sacco, Y Hu, MV Gongora, F Meilleur, MT Kemp… - 2022 - pesquisa.bvsalud.org
The P132H mutation in the main protease of Omicron SARS-CoV-2 decreases thermal
stability without compromising catalysis or small-molecule drug inhibition | PREPRINT-BIORXIV …
stability without compromising catalysis or small-molecule drug inhibition | PREPRINT-BIORXIV …